ALKERMES



Ebit Alterar Data
AbbVie USD 5.24B 1.5B 2024-12
Acadia Pharmaceuticals USD 6.99M 24.66M 2024-12
ALKERMES USD 162.69M 46.46M 2024-12
Amgen USD 4.03B 11M 2024-12
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 4.21B 500M 2024-12
Eli Lilly USD 5.63B 3.88B 2024-12
Gilead Sciences USD 3.11B 144M 2024-12
Intra Cellular Therapies USD -29197000 9.65M 2024-12
Ionis Pharmaceuticals USD -110000000 38M 2024-12
J&J USD 5.35B 1.14B 2024-12
Malin Corporation EUR -2200000 800K 2023-06
Merck USD 5.22B 339M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Otsuka Holdings JPY 44.75B 57.37B 2024-06
Pfizer USD 4.62B 2.42B 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



ALKERMES - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.